| PUBLICATION DETAILS |
Publication Date
December 2003
|
I.S.B.N. (print)
0-476-00092-0 |
|
|
|
| DEVELOPED BY |
New Zealand Guidelines Group (NZGG)
Level 10, Cigna House
40 Mercer Street
PO Box 10 665
Wellington
NEW ZEALAND
Phone: +64 4 471 4180
Fax: +64 4 471 4185
E-mail: info@nzgg.org.nz |
|
|
|
| ENDORSED BY |
|
| REQUIRED TOOLS |
Documents are in PDF format. You'll need the FREE Adobe Acrobat Reader to browse and print them.
|
|
|
| Management of Type 2 Diabetes |
Important Note! If you have a slow modem, the below PDF documents may take a while to download. Try right-clicking and choosing 'Save Target As' to save it to your hard drive and download off-line
Erratum for the Guideline
Page xvi states that metformin is contraindicated if creatinine clearance is less than 60 ml/sec. Creatinine clearance is measured in ml/min and should read, ‘metformin is contraindicated if creatinine clearance is less than 60 ml/min.’ |
|
 |
PDF Format (1503.2 k)
Minimum Download Times (in seconds) - 56k: 214.7s 128k: 107.4s 256k: 53.7s |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
We encourage readers to use this area to submit comments about the guidelines and to draw our attention to errors that inevitably will have been made in a project of this scope. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
